NOVALON PHARMACEUTICAL CORPORATION Trademark

Trademark Overview


On Friday, December 18, 1998, a trademark application was filed for NOVALON PHARMACEUTICAL CORPORATION with the United States Patent and Trademark Office. The USPTO has given the NOVALON PHARMACEUTICAL CORPORATION trademark a serial number of 75608796. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, March 14, 2009. This trademark is owned by Novalon Pharmaceutical Corporation. The NOVALON PHARMACEUTICAL CORPORATION trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Reagents for scientific or medical research use, namely phages used to isolate surrogate ligands of drug targets, and surrogate ligands used to isolate novel chemicals that can be developed into drugs

Reagents for clinical or medical laboratory use, namely phages used to isolate surrogate ligands of drug targets, and surrogate ligands used to isolate novel chemicals that can be developed into drugs

Drug discovery services, namely using phages to isolate surrogate ligands of drug targets, and using surrogate ligands to isolate novel chemicals that can be developed into drugs
novalon pharmaceutical corporation

General Information


Serial Number75608796
Word MarkNOVALON PHARMACEUTICAL CORPORATION
Filing DateFriday, December 18, 1998
Status710 - CANCELLED - SECTION 8
Status DateSaturday, March 14, 2009
Registration Number2576979
Registration DateTuesday, June 11, 2002
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 21, 2001

Trademark Statements


Disclaimer with Predetermined Text"PHARMACEUTICAL CORPORATION"
Goods and ServicesReagents for scientific or medical research use, namely phages used to isolate surrogate ligands of drug targets, and surrogate ligands used to isolate novel chemicals that can be developed into drugs
Goods and ServicesReagents for clinical or medical laboratory use, namely phages used to isolate surrogate ligands of drug targets, and surrogate ligands used to isolate novel chemicals that can be developed into drugs
Goods and ServicesDrug discovery services, namely using phages to isolate surrogate ligands of drug targets, and using surrogate ligands to isolate novel chemicals that can be developed into drugs

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, March 14, 2009
Primary Code001
First Use Anywhere DateMonday, July 28, 1997
First Use In Commerce DateMonday, July 28, 1997

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, March 14, 2009
Primary Code005
First Use Anywhere DateMonday, July 28, 1997
First Use In Commerce DateMonday, July 28, 1997

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, March 14, 2009
Primary Code042
First Use Anywhere DateTuesday, August 13, 1996
First Use In Commerce DateTuesday, August 13, 1996

Trademark Owner History


Party NameNovalon Pharmaceutical Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameNovalon Pharmaceutical Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameNovalon Pharmaceutical Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Saturday, March 14, 2009CANCELLED SEC. 8 (6-YR)
Thursday, September 20, 2007CASE FILE IN TICRS
Tuesday, June 11, 2002REGISTERED-PRINCIPAL REGISTER
Tuesday, October 2, 2001EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 21, 2001PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2001NOTICE OF PUBLICATION
Tuesday, February 27, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 19, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 28, 2000NON-FINAL ACTION MAILED
Friday, December 17, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 1, 1999NON-FINAL ACTION MAILED
Wednesday, June 23, 1999ASSIGNED TO EXAMINER